Journal
EXPERT OPINION ON DRUG DISCOVERY
Volume 4, Issue 11, Pages 1191-1199Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/17460440903369813
Keywords
malaria; plasmodium falciparum; post-genome; vaccine candidate discovery; wheat germ cell-free protein synthesis
Categories
Funding
- Ministry of Education, Culture, Sports, Science, and Technology, Japan [19406009, 21022034]
- Ministry of Health, Labour, and Welfare [H21-Chikyukibo-ippan-005]
- Grants-in-Aid for Scientific Research [19406009, 21022034] Funding Source: KAKEN
Ask authors/readers for more resources
Background: Malaria causes about 300 million illnesses and 1 million deaths annually. The likeliest scenario is the aggravation of this disease due to the re-emergence of drug-resistant parasites and insecticide-resistant mosquitoes. One of the promising solutions to this disease are vaccines. However, until now, not even a single licensed malaria vaccine has been developed despite intensive efforts. Even the efficacy of RTS,S, the most advanced vaccine candidate in the pipeline of malaria vaccine development, is only around 50%. Objective: Against this backdrop, there is an urgency to rapidly enrich the pipeline of vaccine development with novel vaccine candidates that can be discovered by synthesizing and screening a multitude of malaria proteins. Methods: However, to achieve this objective, we require optimal technologies for high-throughput synthesis of quality malaria proteins. Among the various protein synthesis systems, the wheat germ cell-free protein synthesis system is advantageous and successful to this end. Results/conclusion: The wheat germ cell-free protein synthesis system is optimal for accelerating the decoding of malaria genome and hence characterization of malaria proteins and discovery of malaria vaccine candidates.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available